Symptoms and risk factors for long COVID in non-hospitalized adults
University of Birmingham · Health Data Research UK · +12 more institutions
Abstract
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection is associated with a range of persistent symptoms impacting everyday functioning, known as post-COVID-19 condition or long COVID. We undertook a retrospective matched cohort study using a UK-based primary care database, Clinical Practice Research Datalink Aurum, to determine symptoms that are associated with confirmed SARS-CoV-2 infection beyond 12 weeks in non-hospitalized adults and the risk factors associated with developing persistent symptoms. We selected 486,149 adults with confirmed SARS-CoV-2 infection and 1,944,580 propensity score-matched adults with no recorded evidence of SARS-CoV-2 infection. Outcomes included 115 individual…
Citation impact
- FWCI
- 131.45
- Percentile
- 100%
- References
- 31
Authors
37- ASAnuradhaa SubramanianCorresponding
University of Birmingham
- KNKrishnarajah Nirantharakumar
Health Data Research UK, University of Birmingham
- SHSarah Hughes
National Institute for Health and Care Research, NIHR Research Delivery Network, University of Birmingham
- PMPuja Myles
Clinical Practice Research Datalink
- TWTim Williams
Clinical Practice Research Datalink
Topics & keywords
- Medicine
- Anosmia
- Hazard ratio
- Cohort
- Retrospective cohort study
- Cohort study
- Internal medicine
- Proportional hazards model
- Good health and well-being
Funding
- AAstraZeneca
- GGlaxoSmithKline
- GSGilead SciencesAward: COVID-19
- POPatient-Centered Outcomes Research Institute
- EREuropean Respiratory Society
- SUSarcoma UK
- WTWellcome Trust
- SFScar Free Foundation
- MCMacmillan Cancer Support
- UHUniversity Hospitals Birmingham NHS Foundation Trust
- GOGovernment of the United Kingdom
- URUK Research and InnovationAward: COV-LT-0013
- NINational Institute for Health and Care ResearchAwards: NIHR203304, 300688, NIHR132914, COV-LT-0013
- BHBritish Heart Foundation
- UCUniversity College London
- UOUniversity of Birmingham
- APAstellas Pharma
- VAVersus Arthritis
- HLH. Lundbeck A/S
- SRSurgical Reconstruction and Microbiology Research Centre
- FFFoundation for Research in Rheumatology
- H2Horizon 2020 Framework ProgrammeAwards: 731032, 965286
- IEImperial Experimental Cancer Medicine Centre
- MRMedical Research CouncilAwards: MC_PC_21015, MR/P021220/1, COVID-19
- EAEngineering and Physical Sciences Research CouncilAward: H2020
- EAEconomic and Social Research Council
- PGProgramme Grants for Applied Research
- RFResearch for Patient Benefit Programme
- UBUCLH Biomedical Research Centre
- JPJanssen Pharmaceuticals
- UPUCB Pharma
- DSDaiichi Sankyo Europe